0001209191-17-038858.txt : 20170609
0001209191-17-038858.hdr.sgml : 20170609
20170609160730
ACCESSION NUMBER: 0001209191-17-038858
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170607
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: UECKER DARRIN
CENTRAL INDEX KEY: 0001276311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17902990
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD, SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-07
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001276311
UECKER DARRIN
849 MITTEN ROAD, SUITE 104
BURLINGAME
CA
94010
1
1
0
0
CEO and President
Common Stock
2017-06-07
4
A
0
160974
0.00
A
160974
D
Stock Option (right to buy)
30.99
2017-06-07
4
A
0
187286
0.00
A
2017-06-07
2027-06-07
Common Stock
187286
187286
D
Stock Option (right to buy)
30.99
2017-06-07
4
A
0
195000
0.00
A
2017-06-07
2027-06-07
Common Stock
195000
195000
D
Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will fully vest on June 1, 2018, subject to the Reporting Person's continued service as of that date.
The shares subject to the option will vest in equal monthly installments over a four year period that began on June 21, 2016, subject to the Reporting Person's continued service through each vesting date.
The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.
/s/ Brian Dow, as Attorney-in-Fact
2017-06-09